Inmune Bio (INMB) Other Non-Current Assets (2021 - 2025)
Historic Other Non-Current Assets for Inmune Bio (INMB) over the last 5 years, with Q3 2025 value amounting to $746000.0.
- Inmune Bio's Other Non-Current Assets rose 80975.61% to $746000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $746000.0, marking a year-over-year increase of 80975.61%. This contributed to the annual value of $79000.0 for FY2024, which is 3969.47% down from last year.
- Per Inmune Bio's latest filing, its Other Non-Current Assets stood at $746000.0 for Q3 2025, which was up 80975.61% from $570000.0 recorded in Q2 2025.
- Inmune Bio's Other Non-Current Assets' 5-year high stood at $746000.0 during Q3 2025, with a 5-year trough of $49000.0 in Q1 2025.
- Moreover, its 5-year median value for Other Non-Current Assets was $99000.0 (2021), whereas its average is $164470.6.
- Examining YoY changes over the last 5 years, Inmune Bio's Other Non-Current Assets showed a top increase of 80975.61% in 2025 and a maximum decrease of 5377.36% in 2025.
- Quarter analysis of 5 years shows Inmune Bio's Other Non-Current Assets stood at $99000.0 in 2021, then changed by 0.0% to $99000.0 in 2022, then skyrocketed by 32.32% to $131000.0 in 2023, then tumbled by 39.69% to $79000.0 in 2024, then skyrocketed by 844.3% to $746000.0 in 2025.
- Its Other Non-Current Assets was $746000.0 in Q3 2025, compared to $570000.0 in Q2 2025 and $49000.0 in Q1 2025.